NFX — Nuformix Share News
0.000.00%
- £2.89m
- £2.80m
RCS - Nuformix PLC - Appointment of Dr Dan Gooding as Consultant
AnnouncementREG - Nuformix PLC - Change of Auditor
AnnouncementREG - Nuformix PLC - Holding(s) in Company
AnnouncementRCS - Nuformix PLC - Oxilio NXP-001 formulation development contract
AnnouncementREG - Nuformix PLC - Adviser Appointments
AnnouncementREG - Nuformix PLC - Director/PDMR Shareholding
AnnouncementREG - Nuformix PLC - Result of General Meeting
AnnouncementREG - Nuformix PLC - Posting of Circular and Notice of General Meeting
AnnouncementREG - Nuformix PLC - Director/PDMR Shareholding
AnnouncementREG - Nuformix PLC - Holding(s) in Company
AnnouncementREG - Nuformix PLC - Second Price Monitoring Extn
AnnouncementREG - Nuformix PLC - Price Monitoring Extension
AnnouncementREG - Nuformix PLC - Subscription to raise £1.65 million
AnnouncementREG - Nuformix PLC - Half year Report
AnnouncementREG - Nuformix PLC - Positive pre-clinical data on NXP002
AnnouncementREG - Nuformix PLC - Holding(s) in Company
AnnouncementREG - Nuformix PLC - NXP004 patent application filing
AnnouncementREG - Nuformix PLC - Directorate Change
AnnouncementREG - Nuformix PLC - Price Monitoring Extension
Announcement